| Heba K Elzawahry, MD | |
|
3570 Joseph Siewick Dr. Suite 400, Herndon, VA 22033 | |
| (310) 392-8636 | |
| Not Available |
| Full Name | Heba K Elzawahry |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 3570 Joseph Siewick Dr. Suite 400, Herndon, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356507990 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01012385 (Virginia) | Primary |
| 261QC1500X | Clinic/center - Community Health | 131430 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Caregivers Home Health Services, Inc | Falls church, VA | Home health agency |
| Capital Hospice | Falls church, VA | Hospice |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Reston Hospital Center | Reston, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Physician Partners Llc | 2466581772 | 300 |
News Archive
An innovative new technique of partial breast irradiation for early stage breast cancer has been developed in Canada. This technique, a world first, was presented at the annual scientific meeting of the Canadian Association of Radiation Oncologists this week.
The U.S. remains on track to spend twice as much for health care as for food, yet millions are without insurance or uninsured.
Researchers at Sanford Burnham Prebys Medical Discovery and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex, regulating NFκB and other inflammatory molecules, SHARPIN modulates PRMT5, an epigenetic master switch that controls several proteins linked to melanoma. The research was published in The Journal of Clinical Investigation.
The European Association for the Study of Diabetes (EASD) has made an urgent call for more research into a possible link between use of insulin glargine (an insulin analogue) and increased risk of cancer, following evidence from studies in Germany, Sweden and Scotland. However, until this further research becomes available, these experts are stressing that patients with diabetes taking Lantus should continue to do so, although some might wish to consider alternative types of insulin. The studies are reported in Diabetologia (the journal of EASD), edited by Professor Edwin Gale of the University of Bristol.
Labopharm Inc. today commented on the outcome of patent-infringement litigation initiated by Purdue Pharma Products L.P. against Par Pharmaceutical Companies, Inc. relating to Ultram(R) ER (tramadol hydrochloride extended-release tablets).
› Verified 7 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
An innovative new technique of partial breast irradiation for early stage breast cancer has been developed in Canada. This technique, a world first, was presented at the annual scientific meeting of the Canadian Association of Radiation Oncologists this week.
The U.S. remains on track to spend twice as much for health care as for food, yet millions are without insurance or uninsured.
Researchers at Sanford Burnham Prebys Medical Discovery and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex, regulating NFκB and other inflammatory molecules, SHARPIN modulates PRMT5, an epigenetic master switch that controls several proteins linked to melanoma. The research was published in The Journal of Clinical Investigation.
The European Association for the Study of Diabetes (EASD) has made an urgent call for more research into a possible link between use of insulin glargine (an insulin analogue) and increased risk of cancer, following evidence from studies in Germany, Sweden and Scotland. However, until this further research becomes available, these experts are stressing that patients with diabetes taking Lantus should continue to do so, although some might wish to consider alternative types of insulin. The studies are reported in Diabetologia (the journal of EASD), edited by Professor Edwin Gale of the University of Bristol.
Labopharm Inc. today commented on the outcome of patent-infringement litigation initiated by Purdue Pharma Products L.P. against Par Pharmaceutical Companies, Inc. relating to Ultram(R) ER (tramadol hydrochloride extended-release tablets).
› Verified 7 days ago
| Entity Name | Inova Physician Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215264916 PECOS PAC ID: 2466581772 Enrollment ID: O20100525000846 |
News Archive
An innovative new technique of partial breast irradiation for early stage breast cancer has been developed in Canada. This technique, a world first, was presented at the annual scientific meeting of the Canadian Association of Radiation Oncologists this week.
The U.S. remains on track to spend twice as much for health care as for food, yet millions are without insurance or uninsured.
Researchers at Sanford Burnham Prebys Medical Discovery and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex, regulating NFκB and other inflammatory molecules, SHARPIN modulates PRMT5, an epigenetic master switch that controls several proteins linked to melanoma. The research was published in The Journal of Clinical Investigation.
The European Association for the Study of Diabetes (EASD) has made an urgent call for more research into a possible link between use of insulin glargine (an insulin analogue) and increased risk of cancer, following evidence from studies in Germany, Sweden and Scotland. However, until this further research becomes available, these experts are stressing that patients with diabetes taking Lantus should continue to do so, although some might wish to consider alternative types of insulin. The studies are reported in Diabetologia (the journal of EASD), edited by Professor Edwin Gale of the University of Bristol.
Labopharm Inc. today commented on the outcome of patent-infringement litigation initiated by Purdue Pharma Products L.P. against Par Pharmaceutical Companies, Inc. relating to Ultram(R) ER (tramadol hydrochloride extended-release tablets).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heba K Elzawahry, MD 3650 Joseph Siewick Dr Ste 400, Fairfax, VA 22033-1715 Ph: (310) 392-8636 | Heba K Elzawahry, MD 3570 Joseph Siewick Dr. Suite 400, Herndon, VA 22033 Ph: (310) 392-8636 |
News Archive
An innovative new technique of partial breast irradiation for early stage breast cancer has been developed in Canada. This technique, a world first, was presented at the annual scientific meeting of the Canadian Association of Radiation Oncologists this week.
The U.S. remains on track to spend twice as much for health care as for food, yet millions are without insurance or uninsured.
Researchers at Sanford Burnham Prebys Medical Discovery and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex, regulating NFκB and other inflammatory molecules, SHARPIN modulates PRMT5, an epigenetic master switch that controls several proteins linked to melanoma. The research was published in The Journal of Clinical Investigation.
The European Association for the Study of Diabetes (EASD) has made an urgent call for more research into a possible link between use of insulin glargine (an insulin analogue) and increased risk of cancer, following evidence from studies in Germany, Sweden and Scotland. However, until this further research becomes available, these experts are stressing that patients with diabetes taking Lantus should continue to do so, although some might wish to consider alternative types of insulin. The studies are reported in Diabetologia (the journal of EASD), edited by Professor Edwin Gale of the University of Bristol.
Labopharm Inc. today commented on the outcome of patent-infringement litigation initiated by Purdue Pharma Products L.P. against Par Pharmaceutical Companies, Inc. relating to Ultram(R) ER (tramadol hydrochloride extended-release tablets).
› Verified 7 days ago
Dr. Fred Clayton Wilkins Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 104 Anthem Ave, Herndon, VA 20170 Phone: 703-376-7296 | |
Dr. Jason A. Cooper, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 Herndon Parkway, Ste 100, Herndon, VA 20170 Phone: 703-481-1505 Fax: 703-742-8793 | |
Robin L. Donald, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1141 Elden St, Third Floor, Herndon, VA 20170 Phone: 703-481-8160 Fax: 703-435-6752 | |
Mrs. Diviyalaxmi Muruganandam, PA Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 381 Elden St Ste 1000, Herndon, VA 20170 Phone: 703-481-1505 Fax: 703-742-8793 | |
Cynthia Awadzi, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 1141 Elden St Ste 300, Herndon, VA 20170 Phone: 703-840-4705 | |
Dr. Kevin J Lee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 Herndon Parkway, Suite 100, Herndon, VA 20170 Phone: 703-481-1505 Fax: 703-742-8793 | |
Bao-chau Audrey T Nguyen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 600 Herndon Pkwy Ste 200, Herndon, VA 20170 Phone: 703-464-6094 Fax: 703-689-8959 |